• CLSI M23A2

CLSI M23A2

Development of In Vitro Susceptibility Testing Criteria and Quality Control Parameters; Approved Guideline, M23-A2

Clinical and Laboratory Standards Institute, 05/01/2001

Publisher: CLSI

File Format: PDF

$109.00$219.97


Published:01/05/2001

Pages:28

CLSI M23A2 addresses the required and recommended data needed for the selection of appropriate interpretive standards and quality control guidelines for antimicrobial agents.

The U.S. Food and Drug Administration (FDA) has evaluated and recognized this approved-level consensus guideline for use in satisfying a regulatory requirement.

More CLSI standard pdf

CLSI M53-P

CLSI M53-P

Criteria for Laboratory Testing and Diagnosis of HIV Infection; Proposed Guideline, M53P

$145.00 $291.15

CLSI EP28-A3cS (R2018)

CLSI EP28-A3cS (R2018)

Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory; Approved Guideline, Third Edition, EP28A3E

$90.00 $180.00

CLSI I/LA32-A

CLSI I/LA32-A

Newborn Screening by Tandem Mass Spectrometry; Approved Guideline, ILA32A

$140.00 $281.86

CLSI VET03/VET04-S1

CLSI VET03/VET04-S1

Performance Standards for Antimicrobial Susceptibility Testing of Bacteria Isolated From Aquatic Animals; First Informational Supplement,VET03VET04S1E

$117.00 $235.65